Dolutegravir (DTG) + Lamivudine (3 TC) in Antiretroviral-Naive Adults With HIV With and Without Genotypic Resistance Testing Results: 96-Week Effectiveness and Tolerability of REDOLA Study
Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Federico Pulido(Bellvitge University Hospital), Jorge Vergas(Hospital Clínico San Carlos), Álvaro Mena(Universidade da Coruña), Luz Martín‐Carbonero, Francisco Tejerina(Instituto de Salud Carlos III), Adriana Pinto(Centro de Investigación Biomédica en Red), Miguel Torralba(Universidad de Alcalá), Juan Carlos López Bernardo de Quirós(Instituto de Salud Carlos III), Jesús Sanz(Hospital Universitario de La Princesa), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Esmeralda Palmier(Hospital Universitario La Paz), Ángela Gutiérrez(Hospital Universitario Puerta de Hierro Majadahonda)
Cited by 1
Related Papers
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects
|Journal of Infection|2022|174
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170